Carlos Gustavo Trujillo

Carlos Gustavo Trujillo

Auto-generated profile, based on publicly available information

Carlos Gustavo Trujillo

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de los Andes School of Medicine, Bogotá, Colombia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2023 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
LZLaura Zuluaga
Laura Zuluaga
JCJuan Ignacio Caicedo
Juan Ignacio Caicedo
MMMaría Paula Mogollón
María Paula Mogollón
JSJessica Santander
Jessica Santander
ABAlejandra Bravo-Balado
Alejandra Bravo-Balado
MPMauricio Plata
Mauricio Plata

24 September 2018 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
MPMauricio Plata
Mauricio Plata
ABAlejandra Bravo‐Balado
Alejandra Bravo‐Balado
DRDaniela Robledo
Daniela Robledo
CTCarlos G. Trujillo
Carlos G. Trujillo
JCJuan I. Caicedo
Juan I. Caicedo
DLDarío Londoño
Darío Londoño

1 August 2018 in International braz j urol
Verified
Journal Article
Open access
PDF file
CDCristina Dominguez
Cristina Dominguez
MPMauricio Plata
Mauricio Plata
JCJuan Guillermo Cataño
Juan Guillermo Cataño
MPMauricio Palau
Mauricio Palau
DADiego Aguirre
Diego Aguirre
CMCamilo Medina
Camilo Medina
Keywords: Prostatic Neoplasms; Magnetic Resonance Imaging; Prostatectomy

14 August 2020 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
CBCatalina Barco‐Castillo
Catalina Barco‐Castillo
MPMauricio Plata
Mauricio Plata
LZLaura Zuluaga
Laura Zuluaga
ASAdolfo Serrano
Adolfo Serrano
AGAndrea Gómez
Andrea Gómez
CTCarlos Gustavo Trujillo
Carlos Gustavo Trujillo

6 September 2017 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
MPMauricio Plata
Mauricio Plata
ABAlejandra Bravo‐Balado
Alejandra Bravo‐Balado
DRDaniela Robledo
Daniela Robledo
JCJuan C. Castaño
Juan C. Castaño
MAMárcio A. Averbeck
Márcio A. Averbeck
CTCarlos G. Trujillo
Carlos G. Trujillo

1 October 2016 in Urologia Internationalis
Verified
Journal Article
Open access
PDF file
CTCarlos Gustavo Trujillo
Carlos Gustavo Trujillo
MPMauricio Plata
Mauricio Plata
JCJuan Ignacio Caicedo
Juan Ignacio Caicedo
JCJuan Guillermo Cataño Cataño
Juan Guillermo Cataño Cataño
AAAngela Marcela Mariño Alvarez
Angela Marcela Mariño Alvarez
DRDaniela Robledo
Daniela Robledo
Objectives: To determine the impact of rectal swabs (RSs) on infectious complications (IC) following prostate biopsy (PB). Methods: A retrospective cohort study was conducted including all patients subjected to PB between 2009 and 2013. Group B consisted of patients with a RS and group A of patients without. RS reported the presence of gram-positive or negative germs, sensitive or resistant to ciprofloxacin. Antimicrobial prophylaxis was adjusted to the result. Frequency of IC in each group was determined. Results: Group B had 548 (47.20%) patients and group A 613 (52.80%). From group B, 250 (45.62%) of the RSs showed fluoroquinolone (FQ)-resistant germs. Forty nine (16.44%) patients with sensitive germs vs. 147 (59.51%) with resistant germs had a history of previous FQ treatment (p < 0.0001). IC were observed in 33 (5.49%) patients from group A and in 7 (1.28%) patients from group B (p < 0.0001), requiring hospitalization in 4.99 vs. 1.28%, respectively. IC and hospital admissions were reduced in 76.68 and 74.34%, respectively, following the implementation of RS. Conclusions: RS and targeted antibiotic prophylaxis prior to PB was associated with a significant reduction in IC and hospital admissions. Ceftriaxone could be an alternative in cases of known resistance. Past history of FQ treatment is associated with increased resistance.